SNAPC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.059000E-01
Normal-vs-Stage2
7.413800E-01
Normal-vs-Stage3
1.238160E-02
Normal-vs-Stage4
2.584600E-01
Stage1-vs-Stage2
4.326800E-01
Stage1-vs-Stage3
2.022500E-02
Stage1-vs-Stage4
4.687400E-01
Stage2-vs-Stage3
6.444400E-02
Stage2-vs-Stage4
1.781350E-01
Stage3-vs-Stage4
1.582110E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.613000E-01
Normal-vs-AfricanAmerican
6.562200E-01
Normal-vs-Asian
4.003200E-01
Caucasian-vs-AfricanAmerican
9.122800E-01
Caucasian-vs-Asian
3.132000E-01
AfricanAmerican-vs-Asian
5.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.279000E-01
Normal-vs-Female
6.129600E-01
Male-vs-Female
4.200200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.810800E-01
Normal-vs-Age(41-60Yrs)
9.424400E-01
Normal-vs-Age(61-80Yrs)
7.116200E-01
Normal-vs-Age(81-100Yrs)
3.548000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.509600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.474400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.163600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.486000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.410100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.866400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.843600E-01
Normal-vs-Daily Drinker
2.172800E-01
Normal-vs-Weekly Drinker
9.067800E-01
Normal-vs-Occasional Drinker
9.277000E-01
Normal-vs-Social Drinker
9.470000E-01
Non Drinker-vs-Daily Drinker
1.556200E-01
Non Drinker-vs-Weekly Drinker
4.742800E-01
Non Drinker-vs-Occasional Drinker
2.432200E-01
Non Drinker-vs-Social Drinker
4.080800E-01
Daily Drinker-vs-Weekly Drinker
7.569900E-02
Daily Drinker-vs-Occasional Drinker
3.142300E-02
Daily Drinker-vs-Social Drinker
1.087200E-01
Weekly Drinker-vs-Occasional Drinker
7.304200E-01
Weekly Drinker-vs-Social Drinker
7.824000E-01
Occasional Drinker-vs-Social Drinker
9.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.344350E-01
Normal-vs-Grade 2
2.692000E-02
Normal-vs-Grade 3
6.130300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.990770E-01
Grade 1-vs-Grade 3
7.290400E-02
Grade 1-vs-Grade 4
1.344350E-01
Grade 2-vs-Grade 3
2.424400E-01
Grade 2-vs-Grade 4
2.692000E-02
Grade 3-vs-Grade 4
6.130300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.744800E-01
Normal-vs-NonDiabetic
6.167200E-01
Diabetic-vs-NonDiabetic
7.980600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.740200E-01
Normal-vs-NoPancreatitis
6.875800E-01
Pancreatitis-vs-NoPancreatitis
9.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.203400E-01
Normal-vs-N1
7.143400E-01
N0-vs-N1
8.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.973800E-01
Normal-vs-TP53-NonMutant
8.042200E-01
TP53-Mutant-vs-TP53-NonMutant
4.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
